Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opdualag
Pharma
Bristol Myers scraps Opdualag trial in colorectal cancer
The company opted to cut the phase 3 study after an analysis found that the trial was unlikely to achieve its primary endpoints.
Zoey Becker
Dec 18, 2023 10:50am
BMS again cuts staff after disappointing 2Q earnings
Aug 11, 2023 2:41pm
BMS scouts for M&A deals amid multiple new launches: CEO
Apr 27, 2023 1:13pm
BMS goes double DTC with immunotherapy spots
Jan 25, 2023 7:30am
CHMP blesses 11 new drugs but says no to Clovis' Rubraca
Jul 22, 2022 9:55am
ASCO: BMS offers closer look at Opdualag's LAG-3 melanoma win
May 26, 2022 5:00pm